Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
GlobeNewswire, Inc.
Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded utilization among existing customers, and the acquisition of new customers since the Full Market Release in mid-April The Company added new...
IIA Survey Reports Israeli High-Tech at Turning Point as Software Companies Downsize and Hardware Companies Expand
EIN Presswire
Despite layoffs, Israeli high-tech employment remains stable, divide emerges between software and hardware, and AI is beginning to reshape hiring and workforce JERUSALEM, ISRAEL, August 11, 2026 /EINPresswire.com/ -- A new survey conducted by...
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
GlobeNewswire, Inc.
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced its intention to offer its...
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
GlobeNewswire, Inc.
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd....
Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
GlobeNewswire, Inc.
GRAND CAYMAN, Cayman Islands, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for...
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Successfully completed human factors validation study and pharmacokinetic study for Anaphylm™ (dibutepinephrine) sublingual film Remains on track to resubmit Anaphylm NDA to the FDA in Q3 2026 Continues pre-launch medical affairs activities and...
Mount Sinai and PinkStar Enter Collaboration to Advance Breast MRI AI Technology
EIN Presswire
Collaboration to strengthen clinical data foundation behind PinkStar, advancing breast MRI AI technology for enhanced interpretation and early cancer detection RAMAT GAN, ISRAEL, August 11, 2026 /EINPresswire.com/ -- PinkStar, a medical AI...
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy
GlobeNewswire, Inc.
TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody’s Ratings has upgraded Teva’s corporate credit rating to Baa3 from Ba1, an investment-grade rating, with a...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Immix Biopharma, Inc. (“Immix” or the “Company”) (NASDAQ: IMMX). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yum! Brands, Inc. - YUM
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yum! Brands, Inc. (“Yum! Brands” or the “Company”) (NYSE: YUM). Such investors are advised to contact Danielle Peyton at...
Covalent Health Wellness and Aesthetics Introduces the Matrix® Platform: A Revolutionary Approach to Skin Health
EIN Presswire
MIAMI, FL, UNITED STATES, August 7, 2026 /EINPresswire.com/ -- Covalent Health Wellness and Aesthetics is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Israel and the occupied territories: ICRC facilitates voluntary return of 88 individuals to Gaza
International Committee of the Red Cross
At the request and with the agreement of relevant authorities, the ICRC transferred the individuals from Kerem Shalom crossing to Nasser Medical Complex in Gaza. Our team also facilitated their communication with families as needed.
Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers – DVLT
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT) and certain officers.
Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers – PODD
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and certain officers.
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.